Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease
Authors:
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statementEuropean Respiratory Journal, 2018
- Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2017
- Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary DiseaseClinical Infectious Diseases, 2017
- Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease : a prospective cohort studyBMC Pulmonary Medicine, 2017
- Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung DiseaseChest, 2014
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyEuropean Respiratory Journal, 2013
- Biomarkers for tuberculosis disease activity, cure, and relapseThe Lancet Infectious Diseases, 2009
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Long-term results of medical treatment in mycobacterium intracellulare infectionThe American Journal of Medicine, 1979